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INTRODUCTION {#sec1-1}
============

Several reports have shown that three invasive pain procedures, punctate midline myelotomy (PMM), spinal cord stimulation (SCS), and intrathecal drug delivery, can be beneficial to treat chronic pain syndromes and reduce consumption of opioids;\[[@ref4],[@ref5],[@ref8]\] PMM interrupts visceral pain signal transmission and SCS modulates pain signal transmission in the spinal cord, while intrathecal drug delivery systems achieve pain control utilizing smaller doses of opioids closer to the effective receptors. Here, we compared the respective costs of PMM, SCS, and intrathecal pain pump (ITPP) in managing chronic pain syndromes.

METHODS {#sec1-2}
=======

We performed a retrospective chart review for 9 patients with chronic pain syndromes who underwent PMM (3 patients), SCS (3 patients), and ITPP (3 patients) procedures at our institution. Patients had to be \>18 years of age with chronic pain resistant to conventional pain protocols \[[Table 1](#T1){ref-type="table"}\]. We used the Wilcoxon rank-sum test to compare the costs between groups along with a one-way analysis of variance (e.g., comparative length of stay (LOS) between groups) with significance level set to (*P* \< 0.05).

###### 

Exclusion criteria and collected variables.
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RESULTS {#sec1-3}
=======

In the SCS, PMM, and ITPP group patients, respectively, averaged 53, 39.3, and 50.7 years of age. The indications for these chronic pain procedures included: SCS for failed back syndrome, PMM for non-malignant visceral pain, and ITPP; two for chronic visceral cancer pain and one for chronic somatic cancer pain. There were no complications in any of the three groups. For SCS, PMM, and ITPP, SCS had the shortest LOS and ITPP the longest: 1, 3.6 ± 0.6 and 15 ± 5.6 days, respectively. Notably, SCS was significantly more expensive (\$105,234) than PMM (\$71,087) and ITPP (\$79,333): the latter two had comparable average costs \[[Figure 1](#F1){ref-type="fig"} and [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\].

![A bar chart shows the average cost of pain procedures (SCS: Spinal cord stimulator, PMM: Punctate midline myelotomy, ITPP: Intrathecal pain pump).](SNI-11-25-g001){#F1}

###### 

Patients' characteristics, hospital LOS, and procedure-related cost and complications.
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###### 

Results of data analysis.

![](SNI-11-25-t003)

DISCUSSION {#sec1-4}
==========

All three pain procedures (SCS, PMM, and ITPP) achieve good pain control and reduced the consumption of opioids.\[[@ref2],[@ref5],[@ref8]\] PMM, by lesioning the ascending postsynaptic dorsal column fibers above the segmental level of the pain, can result in immediate/ long-lasting relief of visceral pain with a low complication rate.\[[@ref8]\] SCS treats neuropathic, visceral, and somatic pain through inhibition of the pain signal transmission.\[[@ref5]\] ITPP delivers minute doses of opioids intrathecally close to the receptors resulting in pain relief without the untoward side effects of high dose intravenous or oral opioids.\[[@ref2],[@ref7]\]

Relative cost analysis {#sec2-4_1}
----------------------

For PMM, the mean cost was the lowest (\$71,087) with the lowest LOS of 1 day, e.g. it does not require a preimplantation trial or annual maintenance cost. Although ITPP initially cost \$79,333 with the longest mean LOS was 15 days, it had many other drawbacks both treatment and financial; a preimplantation trial, needed intermittent refills, had initial (median of 1.1 year), and late failures (median 5.9 years) required monthly costs of medication (about \$486) and the cost of 1^st^ year -- \$18,00--30,000 versus later complications (\$1000--32,000).\[[@ref3]\] The mean cost of SCS was the highest at \$105,234 with an intermediate mean LOS of 3.3 days. However, SCS also required; a preimplantation trial, trial stimulation costs (\$10,900 and \$24,686), lead-related complications (27%), and a significant annual maintenance cost (\$5071--7277).\[[@ref1],[@ref6]\]

CONCLUSION {#sec1-5}
==========

Three invasive pain procedures SCS, PMM, and ITPP help patients with chronic pain refractory to conventional regimens and may be performed safely and effectively. Here, we found: SCS had the shortest LOS (1 day) and ITPP the longest (15 ± 5.6 days), respectively, but SCS was significantly more expensive (\$105,234) than PMM (\$71,087) or ITPP (\$79,333).
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